Gliomas are a type of primary brain tumour originating from glial cells that support and protect nerve cells in the brain and spinal cord. Here's what to know.

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Strong cash position of $12.1 million expected to fund operations into the second half of 2026Driving lead program, TPI 287, towards Phase 2 study for treatment of glioblastoma multiforme (GBM) ...

One woman received more than 100 cycles of 'unnecessary' chemotherapy treatment at University Hospital Coventry ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted ...

Linda Scelza knew what would happen when she told her son, Ryder, it was “OK to go.” Ryder Scelza took two more breaths and then died in his her arms, she said. He was 21. Ryder Scelza, of Rocky Hill, ...

A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA ...

Strong cash position of $12.1 million expected to fund operations into the second half of 2026Driving lead program, TPI 287, towards Phase 2 study for treatment of glioblastoma multiforme (GBM) HOUSTO ...

Tumor electrophysiological abnormalities, characterized by membrane potential dysregulation, ion channel network remodeling, and microenvironmental ...

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical ...

Adding to this landscape is California-based Kairos Pharma (NYSEAMERICAN: KAPA), a clinical-stage oncology company which is ...